Our ROI: Impact to Date of the Target ALS Innovation Ecosystem

July 9, 2020

Tags

Related News

The ALS Global Research Initiative: Pioneering ALS Research Across the Globe

January 27, 2026

Inside a Global Effort to Understand ALS Resilience

January 27, 2026

Target ALS and Regeneron Partner to Expand Access to a Novel C9orf72 ALS/FTD Mouse Model

January 27, 2026

Target ALS Grantee NRG Therapeutics Advances NRG5051 into Phase I Clinical Trial

January 26, 2026